# Datadog timeline

entity: /record/datadog.md  
id: ent_datadog  


## undated

- undated | registrant_name | Datadog, Inc. | valid | [clm_278BF156370B](/claim/clm_278BF156370B.md)
- undated | ticker | DDOG | valid | [clm_44BDC0A92FF2](/claim/clm_44BDC0A92FF2.md)
- undated | cik | 0001561550 | valid | [clm_6E507FA5C5ED](/claim/clm_6E507FA5C5ED.md)
- undated | fiscal_year_end | 12-31 | valid | [clm_A7FCF6003562](/claim/clm_A7FCF6003562.md)
- undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_C06317F3CE71](/claim/clm_C06317F3CE71.md)
- undated | state_of_incorporation | NV | valid | [clm_CE46A20A7CD8](/claim/clm_CE46A20A7CD8.md)
- undated | listed_on | Nasdaq | valid | [clm_EA62C0011DA1](/claim/clm_EA62C0011DA1.md)
- undated | member_of | [Linux Foundation](/record/linux-foundation.md) | unverified | [clm_10F85BBE223F](/claim/clm_10F85BBE223F.md)
- undated | legal_form | Delaware corporation | unverified | [clm_56A392E2E09C](/claim/clm_56A392E2E09C.md)
- undated | website | https://www.datadoghq.com/ | unverified | [clm_617DE7FAB835](/claim/clm_617DE7FAB835.md)

## 2010

- 2010-03-14 | x_username | datadoghq | unverified | [clm_8FED3A89A246](/claim/clm_8FED3A89A246.md)

## 2012

- 2012-09-10 | x_username | DatadogOps | unverified | [clm_098D9AD8F22F](/claim/clm_098D9AD8F22F.md)

## 2016

- 2016-12-31 to 2017-12-31 | total_equity | -81,691,000 United States dollar | superseded | [clm_33CD509A0430](/claim/clm_33CD509A0430.md)

## 2017

- 2017-12-31 to 2018-12-31 | net_income | -2,570,000 United States dollar | superseded | [clm_128D7361026A](/claim/clm_128D7361026A.md)
- 2017-12-31 to 2018-12-31 | revenue | 100,761,000 United States dollar | superseded | [clm_2912DCA1A6AA](/claim/clm_2912DCA1A6AA.md)
- 2017-12-31 to 2018-06-30 | total_equity | -75,701,000 United States dollar | superseded | [clm_3CD393F3438E](/claim/clm_3CD393F3438E.md)
- 2017-12-31 to 2018-12-31 | research_and_development | 24,734,000 United States dollar | superseded | [clm_569FF2E19582](/claim/clm_569FF2E19582.md)
- 2017-12-31 to 2018-12-31 | operating_income | -2,956,000 United States dollar | superseded | [clm_C1012D3B9181](/claim/clm_C1012D3B9181.md)
- 2017-12-31 to 2018-09-30 | cash_and_equivalents | 60,024,000 United States dollar | superseded | [clm_FC61E72B0A24](/claim/clm_FC61E72B0A24.md)

## 2018

- 2018-06-30 to 2018-09-30 | total_equity | -70,000,000 United States dollar | superseded | [clm_FF39DDBCAD76](/claim/clm_FF39DDBCAD76.md)
- 2018-09-30 to 2019-03-31 | quarterly_net_income | -4,673,000 United States dollar | superseded | [clm_21963645B6C3](/claim/clm_21963645B6C3.md)
- 2018-09-30 to 2018-12-31 | total_equity | -72,772,000 United States dollar | superseded | [clm_834D48B6C119](/claim/clm_834D48B6C119.md)
- 2018-09-30 to 2018-12-31 | cash_and_equivalents | 64,003,000 United States dollar | superseded | [clm_868EF087D6D0](/claim/clm_868EF087D6D0.md)
- 2018-09-30 to 2019-03-31 | quarterly_operating_income | -4,635,000 United States dollar | superseded | [clm_C1FD42423EA5](/claim/clm_C1FD42423EA5.md)
- 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 14,159,000 United States dollar | superseded | [clm_CDD3CA730D97](/claim/clm_CDD3CA730D97.md)
- 2018-09-30 to 2019-03-31 | quarterly_revenue | 51,074,000 United States dollar | superseded | [clm_CEB6FF674DB7](/claim/clm_CEB6FF674DB7.md)
- 2018-12-31 to 2019-12-31 | research_and_development | 55,176,000 United States dollar | superseded | [clm_06363293ABD1](/claim/clm_06363293ABD1.md)
- 2018-12-31 to 2019-03-31 | cash_and_equivalents | 53,639,000 United States dollar | superseded | [clm_2A65A0F6A6C3](/claim/clm_2A65A0F6A6C3.md)
- 2018-12-31 to 2019-12-31 | revenue | 198,077,000 United States dollar | superseded | [clm_76FC81812A7B](/claim/clm_76FC81812A7B.md)
- 2018-12-31 to 2019-12-31 | net_income | -10,762,000 United States dollar | superseded | [clm_D05C968A68B4](/claim/clm_D05C968A68B4.md)
- 2018-12-31 to 2019-12-31 | operating_income | -11,033,000 United States dollar | superseded | [clm_F02544A16966](/claim/clm_F02544A16966.md)
- 2018-12-31 to 2019-09-30 | total_assets | 179,750,000 United States dollar | superseded | [clm_F7FA36A5E5B8](/claim/clm_F7FA36A5E5B8.md)
- 2018-12-31 to 2019-03-31 | total_equity | -76,041,000 United States dollar | superseded | [clm_F81560E83E19](/claim/clm_F81560E83E19.md)

## 2019

- 2019-03-31 to 2019-06-30 | quarterly_revenue | 70,050,000 United States dollar | superseded | [clm_0F06F885A51E](/claim/clm_0F06F885A51E.md)
- 2019-03-31 to 2019-06-30 | quarterly_operating_income | -9,662,000 United States dollar | superseded | [clm_29D8DA1583E5](/claim/clm_29D8DA1583E5.md)
- 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 22,815,000 United States dollar | superseded | [clm_2C29E4A2842E](/claim/clm_2C29E4A2842E.md)
- 2019-03-31 to 2019-06-30 | cash_and_equivalents | 54,554,000 United States dollar | superseded | [clm_4A79094266B7](/claim/clm_4A79094266B7.md)
- 2019-03-31 to 2019-06-30 | quarterly_net_income | -9,491,000 United States dollar | superseded | [clm_84FD4E191E41](/claim/clm_84FD4E191E41.md)
- 2019-03-31 to 2019-06-30 | total_equity | -81,564,000 United States dollar | superseded | [clm_ECCE379916EF](/claim/clm_ECCE379916EF.md)
- 2019-06-30 to 2019-09-30 | quarterly_revenue | 83,222,000 United States dollar | superseded | [clm_17479EDD95C0](/claim/clm_17479EDD95C0.md)
- 2019-06-30 to 2019-09-30 | quarterly_operating_income | -3,994,000 United States dollar | superseded | [clm_382228DD8C5B](/claim/clm_382228DD8C5B.md)
- 2019-06-30 to 2019-09-30 | total_equity | -79,223,000 United States dollar | superseded | [clm_4153462C4E3B](/claim/clm_4153462C4E3B.md)
- 2019-06-30 to 2019-09-30 | cash_and_equivalents | 52,286,000 United States dollar | superseded | [clm_503EE2E005CC](/claim/clm_503EE2E005CC.md)
- 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 24,032,000 United States dollar | superseded | [clm_B41CB3572FA6](/claim/clm_B41CB3572FA6.md)
- 2019-06-30 to 2019-09-30 | quarterly_net_income | -3,949,000 United States dollar | superseded | [clm_BC8E804A67EF](/claim/clm_BC8E804A67EF.md)
- 2019-09-30 to 2019-12-31 | cash_and_equivalents | 760,945,000 United States dollar | superseded | [clm_0EF88A85C89F](/claim/clm_0EF88A85C89F.md)
- 2019-09-30 to 2019-12-31 | total_equity | 771,235,000 United States dollar | superseded | [clm_155B25492089](/claim/clm_155B25492089.md)
- 2019-09-30 to 2020-03-31 | quarterly_operating_income | -4,218,000 United States dollar | superseded | [clm_CD383A4E834D](/claim/clm_CD383A4E834D.md)
- 2019-09-30 to 2020-03-31 | quarterly_revenue | 95,864,000 United States dollar | superseded | [clm_DD964D997C80](/claim/clm_DD964D997C80.md)
- 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 28,684,000 United States dollar | superseded | [clm_DF5416427E5A](/claim/clm_DF5416427E5A.md)
- 2019-09-30 to 2019-12-31 | total_assets | 1,006,753,000 United States dollar | superseded | [clm_E992EF3D305E](/claim/clm_E992EF3D305E.md)
- 2019-09-30 to 2020-03-31 | quarterly_net_income | -4,161,000 United States dollar | superseded | [clm_F302A18F2264](/claim/clm_F302A18F2264.md)
- 2019-12-31 to 2020-03-31 | total_equity | 782,341,000 United States dollar | superseded | [clm_091D17916AA2](/claim/clm_091D17916AA2.md)
- 2019-12-31 to 2020-12-31 | research_and_development | 111,425,000 United States dollar | superseded | [clm_2A2F3C9AE340](/claim/clm_2A2F3C9AE340.md)
- 2019-12-31 to 2020-12-31 | net_income | -16,710,000 United States dollar | superseded | [clm_2A57A82F9435](/claim/clm_2A57A82F9435.md)
- 2019-12-31 to 2020-03-31 | total_assets | 1,038,041,000 United States dollar | superseded | [clm_5745414E76AD](/claim/clm_5745414E76AD.md)
- 2019-12-31 to 2020-03-31 | cash_and_equivalents | 597,297,000 United States dollar | superseded | [clm_8EBBB686C6EE](/claim/clm_8EBBB686C6EE.md)
- 2019-12-31 to 2020-12-31 | operating_income | -20,140,000 United States dollar | superseded | [clm_B88A8183DF3E](/claim/clm_B88A8183DF3E.md)
- 2019-12-31 to 2020-12-31 | revenue | 362,780,000 United States dollar | superseded | [clm_C56DC2D86439](/claim/clm_C56DC2D86439.md)

## 2020

- 2020-03-31 to 2020-06-30 | total_equity | 802,895,000 United States dollar | superseded | [clm_3AB89C736BCE](/claim/clm_3AB89C736BCE.md)
- 2020-03-31 to 2020-06-30 | cash_and_equivalents | 194,350,000 United States dollar | superseded | [clm_45DB4E5557C6](/claim/clm_45DB4E5557C6.md)
- 2020-03-31 to 2020-06-30 | quarterly_revenue | 131,248,000 United States dollar | superseded | [clm_51C269B4A1F0](/claim/clm_51C269B4A1F0.md)
- 2020-03-31 to 2020-06-30 | total_assets | 1,066,656,000 United States dollar | superseded | [clm_8CF3D8A60D7A](/claim/clm_8CF3D8A60D7A.md)
- 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 40,824,000 United States dollar | superseded | [clm_B3C96E426F8F](/claim/clm_B3C96E426F8F.md)
- 2020-03-31 to 2020-06-30 | quarterly_net_income | 6,479,000 United States dollar | superseded | [clm_C49F0F4F8EFF](/claim/clm_C49F0F4F8EFF.md)
- 2020-03-31 to 2020-06-30 | quarterly_operating_income | 3,778,000 United States dollar | superseded | [clm_F586C68A72D0](/claim/clm_F586C68A72D0.md)
- 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 45,664,000 United States dollar | superseded | [clm_0098A98A770F](/claim/clm_0098A98A770F.md)
- 2020-06-30 to 2020-09-30 | quarterly_net_income | 284,000 United States dollar | superseded | [clm_16890462B6BC](/claim/clm_16890462B6BC.md)
- 2020-06-30 to 2020-09-30 | quarterly_revenue | 140,012,000 United States dollar | superseded | [clm_35EF51E45B98](/claim/clm_35EF51E45B98.md)
- 2020-06-30 to 2020-09-30 | cash_and_equivalents | 206,202,000 United States dollar | superseded | [clm_A969AF22949A](/claim/clm_A969AF22949A.md)
- 2020-06-30 to 2020-09-30 | total_assets | 1,783,706,000 United States dollar | superseded | [clm_B3360BADB3C7](/claim/clm_B3360BADB3C7.md)
- 2020-06-30 to 2020-09-30 | total_equity | 912,871,000 United States dollar | superseded | [clm_BA33C295A0ED](/claim/clm_BA33C295A0ED.md)
- 2020-06-30 to 2020-09-30 | quarterly_operating_income | 654,000 United States dollar | superseded | [clm_CDB57990F29C](/claim/clm_CDB57990F29C.md)
- 2020-09-30 to 2020-12-31 | total_assets | 1,814,284,000 United States dollar | superseded | [clm_0642638E049B](/claim/clm_0642638E049B.md)
- 2020-09-30 to 2020-12-31 | total_equity | 936,188,000 United States dollar | superseded | [clm_681F6F8B8EFF](/claim/clm_681F6F8B8EFF.md)
- 2020-09-30 to 2021-03-31 | quarterly_net_income | -15,150,000 United States dollar | superseded | [clm_74171D2F62B6](/claim/clm_74171D2F62B6.md)
- 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 56,440,000 United States dollar | superseded | [clm_9A60251BCF11](/claim/clm_9A60251BCF11.md)
- 2020-09-30 to 2020-12-31 | cash_and_equivalents | 198,523,000 United States dollar | superseded | [clm_B0E4C54793CA](/claim/clm_B0E4C54793CA.md)
- 2020-09-30 to 2021-03-31 | quarterly_operating_income | -9,267,000 United States dollar | superseded | [clm_BA04620B0DEF](/claim/clm_BA04620B0DEF.md)
- 2020-09-30 to 2021-03-31 | quarterly_revenue | 154,675,000 United States dollar | superseded | [clm_F5224908FA68](/claim/clm_F5224908FA68.md)
- 2020-12-31 to 2021-03-31 | cash_and_equivalents | 224,927,000 United States dollar | superseded | [clm_0650E240E1FE](/claim/clm_0650E240E1FE.md)
- 2020-12-31 to 2021-12-31 | net_income | -24,547,000 United States dollar | superseded | [clm_241A7E696C9C](/claim/clm_241A7E696C9C.md)
- 2020-12-31 to 2021-12-31 | operating_income | -13,773,000 United States dollar | superseded | [clm_4925C8F5F595](/claim/clm_4925C8F5F595.md)
- 2020-12-31 to 2021-03-31 | total_equity | 957,432,000 United States dollar | superseded | [clm_593A9B37F293](/claim/clm_593A9B37F293.md)
- 2020-12-31 to 2021-12-31 | revenue | 603,466,000 United States dollar | superseded | [clm_6C8E870B9FC4](/claim/clm_6C8E870B9FC4.md)
- 2020-12-31 to 2021-03-31 | total_assets | 1,890,285,000 United States dollar | superseded | [clm_80D01C8ED004](/claim/clm_80D01C8ED004.md)
- 2020-12-31 to 2021-12-31 | research_and_development | 210,626,000 United States dollar | superseded | [clm_D8633E28F607](/claim/clm_D8633E28F607.md)

## 2021

- 2021-03-31 to 2021-06-30 | total_equity | 841,330,000 United States dollar | superseded | [clm_3019B903FAA1](/claim/clm_3019B903FAA1.md)
- 2021-03-31 to 2021-06-30 | total_assets | 1,952,074,000 United States dollar | superseded | [clm_3BE65C90CF1B](/claim/clm_3BE65C90CF1B.md)
- 2021-03-31 to 2021-06-30 | quarterly_net_income | -13,068,000 United States dollar | superseded | [clm_7019A9A1C833](/claim/clm_7019A9A1C833.md)
- 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 79,266,000 United States dollar | superseded | [clm_957A97300695](/claim/clm_957A97300695.md)
- 2021-03-31 to 2021-06-30 | quarterly_revenue | 198,549,000 United States dollar | superseded | [clm_9AABF4EEC606](/claim/clm_9AABF4EEC606.md)
- 2021-03-31 to 2021-06-30 | cash_and_equivalents | 369,706,000 United States dollar | superseded | [clm_AD9E220568B0](/claim/clm_AD9E220568B0.md)
- 2021-03-31 to 2021-06-30 | quarterly_operating_income | -12,830,000 United States dollar | superseded | [clm_F982DB325BEE](/claim/clm_F982DB325BEE.md)
- 2021-06-30 to 2021-09-30 | quarterly_net_income | -9,362,000 United States dollar | superseded | [clm_0057A2936993](/claim/clm_0057A2936993.md)
- 2021-06-30 to 2021-09-30 | cash_and_equivalents | 247,442,000 United States dollar | superseded | [clm_10DA6DDD772E](/claim/clm_10DA6DDD772E.md)
- 2021-06-30 to 2021-09-30 | total_equity | 912,879,000 United States dollar | superseded | [clm_1EAA59B03C4A](/claim/clm_1EAA59B03C4A.md)
- 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 94,779,000 United States dollar | superseded | [clm_6D4A01D58FF7](/claim/clm_6D4A01D58FF7.md)
- 2021-06-30 to 2021-09-30 | total_assets | 2,076,733,000 United States dollar | superseded | [clm_BDC82F312CC5](/claim/clm_BDC82F312CC5.md)
- 2021-06-30 to 2021-09-30 | quarterly_operating_income | -9,886,000 United States dollar | superseded | [clm_BF9CC976BAF6](/claim/clm_BF9CC976BAF6.md)
- 2021-06-30 to 2021-09-30 | quarterly_revenue | 233,549,000 United States dollar | superseded | [clm_ED04D627EC84](/claim/clm_ED04D627EC84.md)
- 2021-09-30 to 2022-03-31 | quarterly_net_income | -5,484,000 United States dollar | superseded | [clm_14914EFCDDDF](/claim/clm_14914EFCDDDF.md)
- 2021-09-30 to 2022-03-31 | quarterly_revenue | 270,488,000 United States dollar | superseded | [clm_2D1EF7A6D8BC](/claim/clm_2D1EF7A6D8BC.md)
- 2021-09-30 to 2021-12-31 | total_assets | 2,194,173,000 United States dollar | superseded | [clm_8F67E56A0B77](/claim/clm_8F67E56A0B77.md)
- 2021-09-30 to 2022-03-31 | quarterly_operating_income | -4,895,000 United States dollar | superseded | [clm_C6592C6C9560](/claim/clm_C6592C6C9560.md)
- 2021-09-30 to 2021-12-31 | cash_and_equivalents | 286,966,000 United States dollar | superseded | [clm_D885BFE4FC7A](/claim/clm_D885BFE4FC7A.md)
- 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 112,675,000 United States dollar | superseded | [clm_DA46531EC3A9](/claim/clm_DA46531EC3A9.md)
- 2021-09-30 to 2021-12-31 | total_equity | 957,412,000 United States dollar | superseded | [clm_DC759DAE28DF](/claim/clm_DC759DAE28DF.md)
- 2021-12-31 to 2022-12-31 | revenue | 1,028,784,000 United States dollar | superseded | [clm_0C6F4122DF46](/claim/clm_0C6F4122DF46.md)
- 2021-12-31 to 2022-12-31 | research_and_development | 419,769,000 United States dollar | superseded | [clm_1F0DA26BB271](/claim/clm_1F0DA26BB271.md)
- 2021-12-31 to 2022-12-31 | operating_income | -19,156,000 United States dollar | superseded | [clm_4079DF7C824E](/claim/clm_4079DF7C824E.md)
- 2021-12-31 to 2022-03-31 | total_assets | 2,380,794,000 United States dollar | superseded | [clm_5674B4EBFBF7](/claim/clm_5674B4EBFBF7.md)
- 2021-12-31 to 2022-03-31 | total_equity | 1,041,203,000 United States dollar | superseded | [clm_60237A1E4711](/claim/clm_60237A1E4711.md)
- 2021-12-31 to 2022-03-31 | cash_and_equivalents | 270,973,000 United States dollar | superseded | [clm_838FB48B33D9](/claim/clm_838FB48B33D9.md)
- 2021-12-31 to 2022-12-31 | net_income | -20,745,000 United States dollar | superseded | [clm_C1C107B1D54B](/claim/clm_C1C107B1D54B.md)

## 2022

- 2022-03-31 to 2022-06-30 | total_assets | 2,529,015,000 United States dollar | superseded | [clm_20B69DDD39CF](/claim/clm_20B69DDD39CF.md)
- 2022-03-31 to 2022-06-30 | total_equity | 1,116,857,000 United States dollar | superseded | [clm_3A74145529DC](/claim/clm_3A74145529DC.md)
- 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 150,608,000 United States dollar | superseded | [clm_61115D8E9203](/claim/clm_61115D8E9203.md)
- 2022-03-31 to 2022-06-30 | quarterly_net_income | 9,738,000 United States dollar | superseded | [clm_7F8DE97DB71E](/claim/clm_7F8DE97DB71E.md)
- 2022-03-31 to 2022-06-30 | cash_and_equivalents | 271,686,000 United States dollar | superseded | [clm_B59646B69D64](/claim/clm_B59646B69D64.md)
- 2022-03-31 to 2022-06-30 | quarterly_operating_income | 10,414,000 United States dollar | superseded | [clm_D48675D752C4](/claim/clm_D48675D752C4.md)
- 2022-03-31 to 2022-06-30 | quarterly_revenue | 363,030,000 United States dollar | superseded | [clm_F09AB05D7E5E](/claim/clm_F09AB05D7E5E.md)
- 2022-06-30 to 2022-09-30 | total_equity | 1,215,120,000 United States dollar | superseded | [clm_1E1E80592403](/claim/clm_1E1E80592403.md)
- 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 177,699,000 United States dollar | superseded | [clm_23EAD863DBFB](/claim/clm_23EAD863DBFB.md)
- 2022-06-30 to 2022-09-30 | quarterly_operating_income | -3,139,000 United States dollar | superseded | [clm_3E1034FBEED3](/claim/clm_3E1034FBEED3.md)
- 2022-06-30 to 2022-09-30 | cash_and_equivalents | 238,859,000 United States dollar | superseded | [clm_610B0F70621D](/claim/clm_610B0F70621D.md)
- 2022-06-30 to 2022-09-30 | total_assets | 2,654,487,000 United States dollar | superseded | [clm_66137F6977A8](/claim/clm_66137F6977A8.md)
- 2022-06-30 to 2022-09-30 | quarterly_net_income | -4,879,000 United States dollar | superseded | [clm_F8F61A8AEB61](/claim/clm_F8F61A8AEB61.md)
- 2022-06-30 to 2022-09-30 | quarterly_revenue | 406,138,000 United States dollar | superseded | [clm_FD4486780AE0](/claim/clm_FD4486780AE0.md)
- 2022-09-30 to 2023-03-31 | quarterly_operating_income | -31,342,000 United States dollar | superseded | [clm_0174974B5547](/claim/clm_0174974B5547.md)
- 2022-09-30 to 2022-12-31 | total_assets | 2,797,603,000 United States dollar | superseded | [clm_42BCD7E1DE51](/claim/clm_42BCD7E1DE51.md)
- 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 205,388,000 United States dollar | superseded | [clm_75671F0ED4CD](/claim/clm_75671F0ED4CD.md)
- 2022-09-30 to 2022-12-31 | cash_and_equivalents | 294,815,000 United States dollar | superseded | [clm_8BE2BF3401AB](/claim/clm_8BE2BF3401AB.md)
- 2022-09-30 to 2023-03-31 | quarterly_revenue | 436,533,000 United States dollar | superseded | [clm_A7FF68D7129B](/claim/clm_A7FF68D7129B.md)
- 2022-09-30 to 2023-03-31 | quarterly_net_income | -25,985,000 United States dollar | superseded | [clm_AC204AB56746](/claim/clm_AC204AB56746.md)
- 2022-09-30 to 2022-12-31 | total_equity | 1,289,439,000 United States dollar | superseded | [clm_E30993E150A0](/claim/clm_E30993E150A0.md)
- 2022-12-31 to 2023-12-31 | net_income | -50,160,000 United States dollar | superseded | [clm_05EF1EA067AA](/claim/clm_05EF1EA067AA.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 752,351,000 United States dollar | superseded | [clm_069B3D8B2539](/claim/clm_069B3D8B2539.md)
- 2022-12-31 to 2023-03-31 | total_assets | 3,004,852,000 United States dollar | superseded | [clm_319B32B17536](/claim/clm_319B32B17536.md)
- 2022-12-31 to 2023-12-31 | revenue | 1,675,100,000 United States dollar | superseded | [clm_609DEF8DD9B7](/claim/clm_609DEF8DD9B7.md)
- 2022-12-31 to 2023-03-31 | cash_and_equivalents | 338,985,000 United States dollar | superseded | [clm_9A4AD30A30D0](/claim/clm_9A4AD30A30D0.md)
- 2022-12-31 to 2023-12-31 | operating_income | -58,695,000 United States dollar | superseded | [clm_CD4788D00058](/claim/clm_CD4788D00058.md)
- 2022-12-31 to 2023-03-31 | total_equity | 1,410,505,000 United States dollar | superseded | [clm_F2BF46634AE5](/claim/clm_F2BF46634AE5.md)

## 2023

- 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 229,478,000 United States dollar | superseded | [clm_283CDA9B5367](/claim/clm_283CDA9B5367.md)
- 2023-03-31 to 2023-06-30 | cash_and_equivalents | 222,548,000 United States dollar | superseded | [clm_6E6E6ACFDFBE](/claim/clm_6E6E6ACFDFBE.md)
- 2023-03-31 to 2023-06-30 | total_assets | 3,139,744,000 United States dollar | superseded | [clm_9BC7DFB7E027](/claim/clm_9BC7DFB7E027.md)
- 2023-03-31 to 2023-06-30 | quarterly_net_income | -24,086,000 United States dollar | superseded | [clm_B75BC749A6AA](/claim/clm_B75BC749A6AA.md)
- 2023-03-31 to 2023-06-30 | quarterly_revenue | 481,714,000 United States dollar | superseded | [clm_DAD1CC47D7D5](/claim/clm_DAD1CC47D7D5.md)
- 2023-03-31 to 2023-06-30 | total_equity | 1,512,099,000 United States dollar | superseded | [clm_E1386B3C84CB](/claim/clm_E1386B3C84CB.md)
- 2023-03-31 to 2023-06-30 | quarterly_operating_income | -34,970,000 United States dollar | superseded | [clm_E430B82E4368](/claim/clm_E430B82E4368.md)
- 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 239,494,000 United States dollar | superseded | [clm_2470BA24931B](/claim/clm_2470BA24931B.md)
- 2023-06-30 to 2023-09-30 | total_assets | 3,312,173,000 United States dollar | superseded | [clm_2DD6902C9206](/claim/clm_2DD6902C9206.md)
- 2023-06-30 to 2023-09-30 | cash_and_equivalents | 291,304,000 United States dollar | superseded | [clm_5A97B4CA3455](/claim/clm_5A97B4CA3455.md)
- 2023-06-30 to 2023-09-30 | quarterly_operating_income | -22,006,000 United States dollar | superseded | [clm_6C50E3FAFB8C](/claim/clm_6C50E3FAFB8C.md)
- 2023-06-30 to 2023-09-30 | quarterly_net_income | -3,969,000 United States dollar | superseded | [clm_7984BB5F4FC2](/claim/clm_7984BB5F4FC2.md)
- 2023-06-30 to 2023-09-30 | total_equity | 1,649,359,000 United States dollar | superseded | [clm_D5187DC1D790](/claim/clm_D5187DC1D790.md)
- 2023-06-30 to 2023-09-30 | quarterly_revenue | 509,460,000 United States dollar | superseded | [clm_E6EC88B913B6](/claim/clm_E6EC88B913B6.md)
- 2023-09-30 to 2023-12-31 | total_assets | 3,543,302,000 United States dollar | superseded | [clm_0E239F08A08D](/claim/clm_0E239F08A08D.md)
- 2023-09-30 to 2024-03-31 | quarterly_operating_income | -4,230,000 United States dollar | superseded | [clm_2F7429E065A3](/claim/clm_2F7429E065A3.md)
- 2023-09-30 to 2023-12-31 | cash_and_equivalents | 261,309,000 United States dollar | superseded | [clm_3D66C20DA6E3](/claim/clm_3D66C20DA6E3.md)
- 2023-09-30 to 2024-03-31 | quarterly_revenue | 547,536,000 United States dollar | superseded | [clm_57F9076B055C](/claim/clm_57F9076B055C.md)
- 2023-09-30 to 2023-12-31 | total_equity | 1,806,476,000 United States dollar | superseded | [clm_81CD6D097DED](/claim/clm_81CD6D097DED.md)
- 2023-09-30 to 2024-03-31 | quarterly_net_income | 22,630,000 United States dollar | superseded | [clm_E8BEB8F959C9](/claim/clm_E8BEB8F959C9.md)
- 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 240,225,000 United States dollar | superseded | [clm_F1A3013E60EA](/claim/clm_F1A3013E60EA.md)
- 2023-12-31 to 2024-03-31 | cash_and_equivalents | 330,339,000 United States dollar | superseded | [clm_268ABFF4908D](/claim/clm_268ABFF4908D.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 962,447,000 United States dollar | superseded | [clm_4FD025C1E607](/claim/clm_4FD025C1E607.md)
- 2023-12-31 to 2024-03-31 | total_equity | 2,025,354,000 United States dollar | superseded | [clm_8FBB7848D98F](/claim/clm_8FBB7848D98F.md)
- 2023-12-31 to 2024-12-31 | net_income | 48,568,000 United States dollar | superseded | [clm_A23243DCA6E4](/claim/clm_A23243DCA6E4.md)
- 2023-12-31 to 2024-03-31 | total_assets | 3,936,072,000 United States dollar | superseded | [clm_B33222C2B403](/claim/clm_B33222C2B403.md)
- 2023-12-31 to 2024-12-31 | operating_income | -33,464,000 United States dollar | superseded | [clm_C63FD8E400D4](/claim/clm_C63FD8E400D4.md)
- 2023-12-31 to 2024-12-31 | revenue | 2,128,359,000 United States dollar | superseded | [clm_EE704C5683D9](/claim/clm_EE704C5683D9.md)

## 2024

- 2024-03-31 to 2024-06-30 | total_equity | 2,202,355,000 United States dollar | superseded | [clm_5255D2CC0E94](/claim/clm_5255D2CC0E94.md)
- 2024-03-31 to 2024-06-30 | quarterly_revenue | 611,253,000 United States dollar | superseded | [clm_627E6F3BE019](/claim/clm_627E6F3BE019.md)
- 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 269,988,000 United States dollar | superseded | [clm_6A9333B3504A](/claim/clm_6A9333B3504A.md)
- 2024-03-31 to 2024-06-30 | quarterly_net_income | 42,631,000 United States dollar | superseded | [clm_8AB1A4FCE65F](/claim/clm_8AB1A4FCE65F.md)
- 2024-03-31 to 2024-06-30 | quarterly_operating_income | 11,996,000 United States dollar | superseded | [clm_AD23BA25D5F3](/claim/clm_AD23BA25D5F3.md)
- 2024-03-31 to 2024-06-30 | total_assets | 4,141,466,000 United States dollar | superseded | [clm_B2C3F46B935B](/claim/clm_B2C3F46B935B.md)
- 2024-03-31 to 2024-06-30 | cash_and_equivalents | 282,218,000 United States dollar | superseded | [clm_E338633DBAB1](/claim/clm_E338633DBAB1.md)
- 2024-06-30 to 2024-09-30 | quarterly_net_income | 43,824,000 United States dollar | superseded | [clm_03698855CECD](/claim/clm_03698855CECD.md)
- 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 274,599,000 United States dollar | superseded | [clm_0F725C62886B](/claim/clm_0F725C62886B.md)
- 2024-06-30 to 2024-09-30 | quarterly_operating_income | 12,618,000 United States dollar | superseded | [clm_1BC1676A073F](/claim/clm_1BC1676A073F.md)
- 2024-06-30 to 2024-09-30 | quarterly_revenue | 645,279,000 United States dollar | superseded | [clm_3430555B9586](/claim/clm_3430555B9586.md)
- 2024-06-30 to 2024-09-30 | total_equity | 2,407,308,000 United States dollar | superseded | [clm_80F1EE72996C](/claim/clm_80F1EE72996C.md)
- 2024-06-30 to 2024-09-30 | cash_and_equivalents | 410,963,000 United States dollar | superseded | [clm_903DE0C4D2E4](/claim/clm_903DE0C4D2E4.md)
- 2024-06-30 to 2024-09-30 | total_assets | 4,412,391,000 United States dollar | superseded | [clm_E7953A8A42F0](/claim/clm_E7953A8A42F0.md)
- 2024-09-30 to 2025-03-31 | quarterly_operating_income | 20,278,000 United States dollar | superseded | [clm_04730A14D32B](/claim/clm_04730A14D32B.md)
- 2024-09-30 to 2025-03-31 | quarterly_net_income | 51,697,000 United States dollar | superseded | [clm_2B924DA33B9B](/claim/clm_2B924DA33B9B.md)
- 2024-09-30 to 2025-03-31 | quarterly_revenue | 690,016,000 United States dollar | superseded | [clm_46DC780C6E86](/claim/clm_46DC780C6E86.md)
- 2024-09-30 to 2024-12-31 | total_assets | 4,631,471,000 United States dollar | superseded | [clm_B2E1E2AA6671](/claim/clm_B2E1E2AA6671.md)
- 2024-09-30 to 2024-12-31 | total_equity | 2,629,145,000 United States dollar | superseded | [clm_C8B30778B579](/claim/clm_C8B30778B579.md)
- 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 291,802,000 United States dollar | superseded | [clm_E33B8FB419BE](/claim/clm_E33B8FB419BE.md)
- 2024-09-30 to 2024-12-31 | cash_and_equivalents | 337,418,000 United States dollar | superseded | [clm_FEB263DC7574](/claim/clm_FEB263DC7574.md)
- 2024-12-31 to 2025-12-31 | operating_income | 54,284,000 United States dollar | superseded | [clm_157B767C6544](/claim/clm_157B767C6544.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 1,152,703,000 United States dollar | superseded | [clm_3655434C920A](/claim/clm_3655434C920A.md)
- 2024-12-31 to 2025-12-31 | revenue | 2,684,275,000 United States dollar | superseded | [clm_518D286E096E](/claim/clm_518D286E096E.md)
- 2024-12-31 to 2025-03-31 | total_assets | 5,785,339,000 United States dollar | superseded | [clm_6B3D9F87F853](/claim/clm_6B3D9F87F853.md)
- 2024-12-31 to 2025-12-31 | net_income | 183,746,000 United States dollar | superseded | [clm_A41ED8CF4ED0](/claim/clm_A41ED8CF4ED0.md)
- 2024-12-31 to 2025-03-31 | cash_and_equivalents | 1,246,983,000 United States dollar | superseded | [clm_A42F3D8212A4](/claim/clm_A42F3D8212A4.md)
- 2024-12-31 to 2025-03-31 | total_equity | 2,714,363,000 United States dollar | superseded | [clm_E1AA44128770](/claim/clm_E1AA44128770.md)

## 2025

- 2025-01-01 | board_member | Amit Agarwal | valid | [clm_A2F25DEC9F88](/claim/clm_A2F25DEC9F88.md)
- 2025-03-31 to 2025-06-30 | quarterly_operating_income | -12,420,000 United States dollar | superseded | [clm_0AE19C0388F0](/claim/clm_0AE19C0388F0.md)
- 2025-03-31 to 2025-06-30 | total_assets | 6,010,381,000 United States dollar | superseded | [clm_19E5F90D9C59](/claim/clm_19E5F90D9C59.md)
- 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 341,061,000 United States dollar | superseded | [clm_26A2E0133F52](/claim/clm_26A2E0133F52.md)
- 2025-03-31 to 2025-06-30 | quarterly_revenue | 761,553,000 United States dollar | superseded | [clm_9F81D38C50BC](/claim/clm_9F81D38C50BC.md)
- 2025-03-31 to 2025-06-30 | total_equity | 2,916,674,000 United States dollar | superseded | [clm_A42E2C9A4F9C](/claim/clm_A42E2C9A4F9C.md)
- 2025-03-31 to 2025-06-30 | cash_and_equivalents | 1,079,854,000 United States dollar | superseded | [clm_AE8461326B41](/claim/clm_AE8461326B41.md)
- 2025-03-31 to 2025-06-30 | quarterly_net_income | 24,642,000 United States dollar | superseded | [clm_C168F1D4BEAE](/claim/clm_C168F1D4BEAE.md)
- 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 387,482,000 United States dollar | superseded | [clm_18A550CC93E2](/claim/clm_18A550CC93E2.md)
- 2025-06-30 to 2025-09-30 | quarterly_operating_income | -35,500,000 United States dollar | superseded | [clm_1D83AB6472C7](/claim/clm_1D83AB6472C7.md)
- 2025-06-30 to 2025-09-30 | quarterly_revenue | 826,760,000 United States dollar | superseded | [clm_72650DE45F7F](/claim/clm_72650DE45F7F.md)
- 2025-06-30 to 2025-09-30 | quarterly_net_income | 2,647,000 United States dollar | superseded | [clm_7D5C3C15F22A](/claim/clm_7D5C3C15F22A.md)
- 2025-06-30 to 2025-09-30 | cash_and_equivalents | 489,030,000 United States dollar | superseded | [clm_961EA8A705D3](/claim/clm_961EA8A705D3.md)
- 2025-06-30 to 2025-09-30 | total_equity | 3,195,757,000 United States dollar | superseded | [clm_F0646F2129B8](/claim/clm_F0646F2129B8.md)
- 2025-06-30 to 2025-09-30 | total_assets | 5,822,415,000 United States dollar | superseded | [clm_F93B93D764E3](/claim/clm_F93B93D764E3.md)
- 2025-09-11 | board_member | Ami Vora | valid | [clm_D611A2836397](/claim/clm_D611A2836397.md)
- 2025-09-30 to 2026-03-31 | quarterly_operating_income | -5,809,000 United States dollar | superseded | [clm_0427E620E071](/claim/clm_0427E620E071.md)
- 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 401,982,000 United States dollar | superseded | [clm_0986D96BD44E](/claim/clm_0986D96BD44E.md)
- 2025-09-30 to 2025-12-31 | cash_and_equivalents | 540,602,000 United States dollar | superseded | [clm_3676212998A8](/claim/clm_3676212998A8.md)
- 2025-09-30 to 2026-03-31 | quarterly_net_income | 33,885,000 United States dollar | superseded | [clm_624B2C762F84](/claim/clm_624B2C762F84.md)
- 2025-09-30 to 2025-12-31 | total_equity | 3,439,118,000 United States dollar | superseded | [clm_77C31B9CAA75](/claim/clm_77C31B9CAA75.md)
- 2025-09-30 to 2026-03-31 | quarterly_revenue | 885,651,000 United States dollar | superseded | [clm_C2631419A60E](/claim/clm_C2631419A60E.md)
- 2025-09-30 to 2025-12-31 | total_assets | 6,052,470,000 United States dollar | superseded | [clm_CA514661F85F](/claim/clm_CA514661F85F.md)
- 2025-12-31 | operating_income | -44,373,000 United States dollar | valid | [clm_0AB18022873C](/claim/clm_0AB18022873C.md)
- 2025-12-31 | research_and_development | 1,548,451,000 United States dollar | valid | [clm_3A886E1D6D48](/claim/clm_3A886E1D6D48.md)
- 2025-12-31 | revenue | 3,427,158,000 United States dollar | valid | [clm_8219CDB7B37B](/claim/clm_8219CDB7B37B.md)
- 2025-12-31 to 2026-03-31 | total_assets | 6,643,844,000 United States dollar | superseded | [clm_9B2965274345](/claim/clm_9B2965274345.md)
- 2025-12-31 to 2026-03-31 | cash_and_equivalents | 401,305,000 United States dollar | superseded | [clm_BC7FA1BCFAC9](/claim/clm_BC7FA1BCFAC9.md)
- 2025-12-31 to 2026-03-31 | total_equity | 3,732,206,000 United States dollar | superseded | [clm_BD966DD64A35](/claim/clm_BD966DD64A35.md)
- 2025-12-31 | net_income | 107,741,000 United States dollar | valid | [clm_E2FB7E6DAA02](/claim/clm_E2FB7E6DAA02.md)

## 2026

- 2026-02-26 | board_member | Dominic Phillips | valid | [clm_FB9550F2CE4A](/claim/clm_FB9550F2CE4A.md)
- 2026-03-31 to 2026-06-30 | total_equity | 3,988,222,000 United States dollar | superseded | [clm_05AF0CC9F34D](/claim/clm_05AF0CC9F34D.md)
- 2026-03-31 to 2026-06-30 | total_assets | 6,952,012,000 United States dollar | superseded | [clm_690F9EAA0892](/claim/clm_690F9EAA0892.md)
- 2026-03-31 to 2026-06-30 | cash_and_equivalents | 426,360,000 United States dollar | superseded | [clm_7A4720BCAA3B](/claim/clm_7A4720BCAA3B.md)
- 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 435,298,000 United States dollar | superseded | [clm_BB4D77A9B3EC](/claim/clm_BB4D77A9B3EC.md)
- 2026-03-31 to 2026-06-30 | quarterly_net_income | 52,574,000 United States dollar | superseded | [clm_C312ECFFAAF4](/claim/clm_C312ECFFAAF4.md)
- 2026-03-31 to 2026-06-30 | quarterly_operating_income | 7,327,000 United States dollar | superseded | [clm_D403C9181E0B](/claim/clm_D403C9181E0B.md)
- 2026-03-31 to 2026-06-30 | quarterly_revenue | 1,006,426,000 United States dollar | superseded | [clm_E18A69B15B46](/claim/clm_E18A69B15B46.md)
- 2026-06-30 | quarterly_net_income | 44,558,000 United States dollar | valid | [clm_08D1544C2097](/claim/clm_08D1544C2097.md)
- 2026-06-30 | cash_and_equivalents | 434,957,000 United States dollar | valid | [clm_0CAA55EA3F12](/claim/clm_0CAA55EA3F12.md)
- 2026-06-30 | total_assets | 7,547,675,000 United States dollar | valid | [clm_310AD9B1C301](/claim/clm_310AD9B1C301.md)
- 2026-06-30 | quarterly_revenue | 1,121,454,000 United States dollar | valid | [clm_69399C9B5706](/claim/clm_69399C9B5706.md)
- 2026-06-30 | total_equity | 4,367,160,000 United States dollar | valid | [clm_B65BA857B658](/claim/clm_B65BA857B658.md)
- 2026-06-30 | quarterly_operating_income | 5,455,000 United States dollar | valid | [clm_C18D484BCFFD](/claim/clm_C18D484BCFFD.md)
- 2026-06-30 | quarterly_research_and_development | 477,968,000 United States dollar | valid | [clm_F69F2A0DC966](/claim/clm_F69F2A0DC966.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.